FOND NAT TRANSFUSION SANGUINE has a total of 45 patent applications. Its first patent ever was published in 1988. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are FONDATION NALE TRANSFUSION SAN, MGVS LTD and LILLE TRANSFUSION SANGUINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 16 | |
#2 | EPO (European Patent Office) | 13 | |
#3 | Canada | 4 | |
#4 | United States | 4 | |
#5 | Denmark | 1 | |
#6 | Finland | 1 | |
#7 | France | 1 | |
#8 | Ireland | 1 | |
#9 | Italy | 1 | |
#10 | Norway | 1 | |
#11 | Poland | 1 | |
#12 | Portugal | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Foods and drinks | |
#5 | Measurement | |
#6 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Object sterilising | |
#5 | Enzymes | |
#6 | Syringes | |
#7 | Therapeutic chemical compounds | |
#8 | Analysing materials | |
#9 | Food proteins | |
#10 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Chabbat Jacques | 11 |
#2 | Steinbuch Marion | 8 |
#3 | Ropars Claude | 6 |
#4 | Lambin Patrick | 6 |
#5 | Boffa Georges | 5 |
#6 | Taby Olivier | 5 |
#7 | Basuyaux Bertrand | 4 |
#8 | Courteille Frederic | 4 |
#9 | Laroze Alain | 4 |
#10 | Schmitthaeusler Roland | 4 |
Publication | Filing date | Title |
---|---|---|
US5700426A | Method for decontaminating or sterilizing "in situ" a vacuum sealed container and device for implementing such method | |
US5589389A | Apparatus for causing medicinal products to penetrate into red blood cells | |
WO9218630A1 | Compound comprising a peptide sequence neutralizing the infection by human cytomegalovirus (hcmv) and composition containing such compound | |
EP0596881A1 | Expression in non-tumoral human lymphoblastoid lines with an integrative vector | |
CA2113464A1 | Expression in non-tumoral human lymphoblastoid lines with an integrative vector | |
PT94859A | Process for the pasteurization of a mixture of proteins containing fibrinogen | |
FR2646917A1 | METHOD FOR DETERMINING ANTI-ALLERGEN SPECIFIC IGG ANTI-BODY, IGG4-RICH FRACTION OBTAINED ACCORDING TO THIS PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION |